Heron Therapeutics | Pre Utilidad Fiscal





Pre Utilidad Fiscal Cambio Fecha
ALKERMES USD 100.74M 4.1M 2025-09
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
Amarin USD -8.12M 5.34M 2025-09
ANI Pharmaceuticals USD 49.52M 39M 2025-09
Anika Therapeutics USD -3.87M 32.43M 2025-03
Arrowhead Research USD 28.27M 7.85M 2025-12
Eisai JPY 22B 7.47B 2025-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Heron Therapeutics USD -4.85M 4.39M 2024-09
Insmed USD -368.7M 48.26M 2025-09
Ligand Pharmaceuticals USD 141.14M 102M 2025-09
Merck USD 6.74B 22M 2025-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Neurocrine Biosciences USD 291.8M 132.3M 2025-09
Omeros USD -65.12M 21.27M 2024-06
Pacira USD -1.93M 10.63M 2025-06
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Surmodics USD -7.51M 1.69M 2024-09
Ultragenyx Pharmaceutical USD -179.54M 65.54M 2025-09
Veracyte USD 18.89M 17.64M 2025-09
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09


Heron Therapeutics Pre Utilidad Fiscal - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.